{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T07:25:46Z","timestamp":1745825146638,"version":"3.37.0"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cdr1p is the major ATP-binding cassette multidrug transporter conferring resistance to azoles and other antifungals in<jats:italic>Candida albicans<\/jats:italic>. In this study, the identification of new Cdr1p inhibitors by use of a newly developed high-throughput fluorescence-based assay is reported. The assay also allowed monitoring of the activity and inhibition of the related transporters Pdr5p and Snq2p of<jats:italic>Saccharomyces cerevisiae<\/jats:italic>, which made it possible to compare its performance with those of previously established procedures. A high sensitivity, resulting from a wide dynamic range, was achieved upon high-level expression of the Cdr1p, Pdr5p, and Snq2p transporters in an<jats:italic>S. cerevisiae<\/jats:italic>strain in which the endogenous interfering activities were further reduced by genetic manipulation. An analysis of a set of therapeutically used and newly synthesized phenothiazine derivatives revealed different pharmacological profiles for Cdr1p, Pdr5p, and Snq2p. All transporters showed similar sensitivities to M961 inhibition. In contrast, Cdr1p was less sensitive to inhibition by fluphenazine, whereas phenothiazine selectively inhibited Snq2p. The inhibition potencies measured by the new assay reflected the ability of the compounds to potentiate the antifungal effect of ketoconazole (KTC), which was detoxified by the overproduced transporters. They also correlated with the 50% inhibitory concentration for inhibition of Pdr5p-mediated transport of rhodamine 6G in isolated plasma membranes. The most active derivative, M961, potentiated the activity of KTC against an azole-resistant<jats:italic>CDR1<\/jats:italic>-overexpressing<jats:italic>C. albicans<\/jats:italic>isolate.<\/jats:p>","DOI":"10.1128\/aac.00956-08","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T01:54:59Z","timestamp":1233626099000},"page":"1516-1527","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["New High-Throughput Screening Assay To Reveal Similarities and Differences in Inhibitory Sensitivities of Multidrug ATP-Binding Cassette Transporters"],"prefix":"10.1128","volume":"53","author":[{"given":"Marcin","family":"Kolaczkowski","sequence":"first","affiliation":[{"name":"Department of Biophysics, Wroclaw Medical University, Ul. Chalubinskiego 10, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kolaczkowska","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Ul. Norwida 31, 50-375 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Motohashi","sequence":"additional","affiliation":[{"name":"Meiji Pharmaceutical University, 2-522-1 Noshio, Tokyo 2048588, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Michalak","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Wroclaw Medical University, Ul. Chalubinskiego 10, 50-368 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)42155-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00330984"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.leu.2400695","volume":"11","year":"1997","unstructured":"Bosch, I., C. L. Crankshaw, D. Piwnica-Worms, and J. M. Croop. 1997. Characterization of functional assays of multidrug resistance P-glycoprotein transport activity. Leukemia11:1131-1137.","journal-title":"Leukemia"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.61.4.1614-1619.1995"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1021\/bi000040f","volume":"39","year":"2000","unstructured":"Conseil, G., A. Decottignies, J. M. Jault, G. Comte, D. Barron, A. Goffeau, and A. Di Pietro. 2000. Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry39:6910-6917.","journal-title":"Biochemistry"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.30.18150"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99946-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00583901"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1021\/bi983038l","volume":"38","year":"1999","unstructured":"Dey, S., P. Hafkemeyer, I. Pastan, and M. M. Gottesman. 1999. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol. Biochemistry38:6630-6639.","journal-title":"Biochemistry"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0076-6879(88)57100-8","volume":"157","year":"1988","unstructured":"Dufour, J. P., A. Amory, and A. Goffeau. 1988. Plasma membrane ATPase from the yeast Schizosaccharomyces pombe. Methods Enzymol.157:513-528.","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_12_2","first-page":"432","year":"1991","unstructured":"Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams and Wilkins Co., Baltimore, MD.","journal-title":"Antibiotics in laboratory medicine"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1712"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)00045-6","volume":"42","year":"1990","unstructured":"Ford, J. M., and W. N. Hait. 1990. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev.42:155-190.","journal-title":"Pharmacol. Rev."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.4.732"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/yea.320110408"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(83)01013-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/0968768031000045815","volume":"20","year":"2003","unstructured":"Hendrich, A. B., O. Weso\u0142owska, A. Po\u0142a, N. Motohashi, J. Moln\u00e1r, and K. Michalak. 2003. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. Mol. Membr. Biol.20:53-60.","journal-title":"Mol. Membr. Biol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)80566-3"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.719-726.2003"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.4.2998"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.7.4653-4661.1994"},{"key":"e_1_3_2_24_2","first-page":"4665","volume":"51","year":"1991","unstructured":"Kessel, D., W. T. Beck, D. Kukuruga, and V. Schulz. 1991. Characterization of multidrug resistance by fluorescent dyes. Cancer Res.51:4665-4670.","journal-title":"Cancer Res."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.02.045"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1998.4.143"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0924-8579(03)00214-0","volume":"22","year":"2003","unstructured":"Kolaczkowski, M., K. Michalak, and N. Motohashi. 2003. Phenothiazines as potent modulators of yeast multidrug resistance. Int. J. Antimicrob. Agents22:279-283.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.49.31543"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/125.1.13"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1021\/bi0018786","volume":"39","year":"2000","unstructured":"Liu, R., A. Siemiarczuk, and F. J. Sharom. 2000. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry39:14927-14938.","journal-title":"Biochemistry"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.41.25167"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2373-2381.2000"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2404"},{"key":"e_1_3_2_36_2","first-page":"590","volume":"53","year":"2003","unstructured":"Motohashi, N., M. Kawase, J. Moln\u00e1r, L. Ferenczy, O. Wesolowska, A. B. Hendrich, M. Bobrowska-H\u00e4gerstrand, H. H\u00e4gerstrand, and K. Michalak. 2003. Antimicrobial activity of N-acylphenothiazines and their influence on lipid model membranes and erythrocyte membranes. Arzneimittelforschung53:590-599.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002530051525","volume":"52","year":"1999","unstructured":"Munder, T., and A. Hinnen. 1999. Yeast cells as tools for target oriented screening. Appl. Microbiol. Biotechnol.52:311-320.","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3366-3374.2001"},{"key":"e_1_3_2_39_2","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards Wayne PA."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1256-1271.2004"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3551-3557.2002"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152606784112164"},{"key":"e_1_3_2_44_2","first-page":"320","volume":"4","year":"1995","unstructured":"Prasad, R., P. De Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet.4:320-329.","journal-title":"Curr. Genet."},{"key":"e_1_3_2_45_2","first-page":"165","volume":"30","year":"1992","unstructured":"Ramu, A., and N. Ramu. 1992. Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother. Pharmacol.30:165-173.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(02)50968-X"},{"key":"e_1_3_2_47_2","first-page":"349","year":"2002","unstructured":"Sanglard, D., and J. Bille. 2002. Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections, p. 349-387. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, DC.","journal-title":"Candida and candidiasis."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.10.2300"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-143-2-405"},{"key":"e_1_3_2_50_2","unstructured":"Assay and reagent kit for evaluation of multi-drug resistance in cells. 2001"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00277115"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.2.6.1361-1375.2003"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/122.1.19"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.106.057596"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.110"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2008.06143.x"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.046532"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1914"},{"key":"e_1_3_2_60_2","first-page":"1704","volume":"6","year":"2002","unstructured":"White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother.6:1704-1713.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0061(20000115)16:1<65::AID-YEA508>3.0.CO;2-M"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2001.00666.x"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00956-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00956-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:34:53Z","timestamp":1738924493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00956-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1128\/AAC.00956-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.00956-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"2008-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-01-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}